In this regard, we have found reduced Y/S IRS1 ratio in AD patients, which likely corresponds to increased insulin resistance, particularly affecting brain regions suffering from AD pathology (Talbot et al., 2012; Kapogiannis et al., 2015; Mullins et al., 2017). The gene discussed is IRS1; the disease is Alzheimer disease.